TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Poverty Play Key Role In Excess Cancer Deaths Among Minorities, President’s Cancer Panel Hears July 26, 1991
TCL Archive Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials December 2, 1977
TCL Archive Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal. June 27, 2003
TCL Archive In Brief: Albert and Mary Lasker Foundation announce 2014 award winners September 12, 2014
